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Abstract
Glutamatergic synapses play critical roles in brain functions and diseases. Long-term potentiation
(LTP) is a most effective cellular model for investigating the synaptic changes that underlie learning
as well as brain disease – although different molecular mechanisms are likely involved in LTP in
physiological and pathological conditions. In the case of learning, N-methyl-D-aspartate (NMDA)
receptor is known to be important for triggering learning-related plasticity; alpha-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic (AMPA) receptors are thought to be important for the
expression of synaptic changes. In this review, I will examine recent evidence on the novel roles of
NMDA receptors, in particular NR2B subunit-containing NMDA receptors in learning and chronic
pain. A positive feedback control of NR2B receptor subunit is proposed to explain cortical
sensitization involved in chronic pain, but not learning and memory.
Introduction
The NMDA receptor acts as an activity-dependent coinci-
dence detector in the central nervous system (CNS). The
majority of past research has focused on the synaptic
changes – namely presynaptic changes in glutamate
release, and postsynaptic AMPA receptor changes – fol-
lowing the activation of the NMDA receptor. Few review
articles are available about the potential long-term plastic
changes in NMDA receptor subunits, in particular NR2B
subunit. In this review, by focusing on physiological
(memory) and pathological (chronic pain) functions, I
will examine previous and recent evidence for long-term
plastic changes of NMDA receptor NR2B subunit in the
central sensory and 'learning' synapses, as well as the
molecular machinery that may contribute to NMDA
receptor NR2B subunit trafficking and postsynaptic inser-
tion.
LTP as a cellular model for brain plasticity
It is well known that central synapses are highly plastic,
and long-term changes in synaptic transmission contrib-
ute to different functions of the brain throughout the
lifespan. Two major forms of synaptic plasticity have been
widely investigated: long-term potentiation (or called
LTP) and long-term depression (or called LTD). While
LTP can enhance synaptic functions in certain regions of
the brain, LTD attenuates or reduces the efficacy of synap-
tic transmission. Such biphasic synaptic plasticity is not
limited at excitatory, glutamatergic synapses. Both LTP
and LTD have been also reported in inhibitory synapses,
and underlying cellular and molecular mechanisms are
different. Recent studies using different induction proto-
cols reveal that the mechanisms for central LTP are likely
to be different, depending the induction protocols,
regions of the CNS, input fibers and postsynaptic neurons
recorded [1-5]. There is no doubt that many different
molecular targets will be continuously revealed in future,
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ical relevant of synaptic LTP/LTD induced by experimen-
tal induction protocols. Furthermore, new forms of LTP
and LTD remain to be discovered to mimic physiological
and/or pathological changes under in vivo conditions
(e.g., presynaptic enhancement of neurotransmitter
release after tissue injury in the anterior cingulate cortex
(ACC) (see [6]).
What has been recognized about the potential functions
of LTP is its contribution to many key brains functions in
addition to learning and memory [7-11]. At the spinal
cord dorsal horn where the first sensory synapses are
located, LTP of sensory synaptic transmission can be
induced by different experimental protocols [12-14] or
peripheral injury [14]. Potentiated excitatory synaptic
transmission is believed to contribute to spinal sensitiza-
tion that at least in part attributes to behavioral hyperalge-
sia and allodynia during chronic pain. In the basolateral
amygdala, LTP can be induced between thalamic/cortical
inputs and postsynaptic principle neurons [15] or fear
conditions [11], such enhanced responses are important
for encoding fearful information. In the hippocampal
CA1 region where most of LTP studies have been reported,
LTP can be induced and reliable detected, even with field
recording electrodes [7,8]. However, despite a huge
amount of literature on hippocampal LTP, it remains to
be demonstrated that if a simple spatial training trial may
induce LTP in certain population of CA1 neurons.
Finally, in the prefrontal cortical (PFC) neurons including
the ACC, LTP is induced by the pairing, spike-timing and
theta burst protocols [16] as well as peripheral injury
[17,6]. It has been proposed that the injury caused synap-
tic potentiation contribute to chronic pain and pain-
related high brain functions including fear and emotion
[18]. Therefore, it is clear that studying central LTP pro-
vides fundamental mechanisms for brain functions –
from pain transmission to fear and chronic pain.
NMDA receptor and LTP
One major feature of LTP is the requirement of activation
of NMDA receptors. As compared with downstream sign-
aling protein inhibitors, the inhibition of NMDA receptor
by bath application of AP-5 reliably blocks the induction
of LTP. In most cases, basal synaptic responses are not
affected the same application of AP-5, indicating the selec-
tive roles of NMDA receptors in the induction. The key
mechanism for the involvement of NMDA receptor in the
induction of LTP is its voltage-dependence. At resting
membrane potentials, NMDA receptors are inactive due to
pore blockade by extracellular Mg2+, even in the presence
of glutamate. Thus, in order to activate NMDA receptors at
synapses, two events need to happen simultaneously.
First, glutamate needs to be released and binds to NMDA
receptors; second, the postsynaptic membrane needs to be
depolarized so that the block by extracellular Mg2+ can be
removed. NMDA receptor-mediated calcium influx from
the extracellular space into the postsynaptic cells then acti-
vates a series of signaling molecules within postsynaptic
cells, including protein kinases, protein phosphatases,
immediate early genes (i.e., genes can be activated rapidly,
or called third messengers), as well as enzymes producing
diffusible retrograde messengers. Although the require-
ment for NMDA receptor in LTP is easily found, applica-
tion of NMDA did not cause synaptic potentiation [7],
making biochemical studies of LTP difficult.
The requirement of the activation of NMDA receptors in
synaptic LTP is common among many brain regions. In
the spinal cord dorsal horn neurons, LTP of AMPA recep-
tor mediated EPSCs were induced by the induction proto-
col that paired synaptic stimulation (2 Hz) with
postsynaptic depolarization (+30 mV) [12]. In the amy-
gdala, LTP induced by the pairing protocol is blockaded
by NMDA receptor antagonist AP-5 [19]. In the ACC, bath
application of a NMDA receptor antagonist AP-5 com-
pletely abolished the induction of LTP induced by differ-
ent induction protocols in the pyramidal cells [16],
indicting that the induction of ACC LTP is completely
dependent of postsynaptic activation of NMDA receptors.
NMDA receptor independent LTP
NMDA receptor independent LTP have been also
reported. Most of these experiments showing NMDA
receptor independent LTP are performed in the presence
of a NMDA receptor blocker. It has to be noted that some
experiments only used a sub-dose of AP-5. It is critical to
demonstrate by whole-cell patch-clamp recording that the
same dosage of NMDA receptor antagonist does in fact
completely eliminate NMDA receptor mediated excitatory
postsynaptic currents (EPSCs) [16]. Depending on the
regions of the CNS and the stimulation protocols, there
are many reports of NMDA receptor as an independent
form of LTP. Several neurotransmitter receptors or ion
channels have been implicated in the initiation of LTP,
such as L-type voltage gated calcium channels (L-VGCCs),
metabotropic glutamate receptors (mGluRs), serotonin
receptors, dopamine receptors and kainate (KA) receptors.
For example, in the hippocampus, in the presence of AP-
5, very strong tetanic stimulation or bath application of
TEA induced LTP that is sensitive to the blockade of L-
VGCCs [20,21]. Bath application of tACPD, an agonist of
mGluRs, produced long-lasting potentiation that may
require cGMP-related signaling pathways [22]. In a recent
study using gene knockout of KA receptor subtype 6 (KA
GluR6) mice, the pairing induced LTP was reduced or
blocked in the ACC and amygdala, suggesting that KA
receptor may contribute to synaptic potentiation [23].Page 2 of 11
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Functional NMDA receptors contain heteromeric combi-
nations of the NR1 subunit plus one or more of NR2A-D.
While NR1 distributes ubiquitously in the CNS, NR2 sub-
units exhibit regional distribution, and the amount of
expression is developmentally related. In the neonatal
brains, NR2B and NR2D subunits are highly expressed,
and over the course of development, they are substituted
or replaced by NR2A and NR2C. In humans and rodents,
NR2A and NR2B subunits predominate in forebrain struc-
tures [24,25]. NR2A and NR2B subunits confer distinct
properties to NMDA receptors; heteromers containing
NR1 plus NR2B mediate a current that decays three to four
times more slowly than receptors composed of NR1 plus
NR2A [25-27]. Unlike other ionotropic channels, NMDA
receptors are 5–10 times more permeable to calcium, a
critical intracellular signaling molecule for triggering post-
synaptic and possible presynaptic plastic changes, than to
Na+ or K+. NMDA receptor mediated currents are long-
lasting compared with the rapidly desensitizing kinetics of
AMPA and KA receptor channels.
Contribution of NR2B-containing NMDA 
receptors to synaptic LTP
The requirement of NR2B-NMDA receptors in synaptic
potentiation has been reported in different areas of the
CNS (see Table 1). Considering the NMDA receptor medi-
ated currents are largely carried out by NR2A-containing
NMDA receptors, one expects that inhibition of NR2B
receptor alone may not be sufficient to produce complete
blockade of synaptic potentiation. Indeed, in the ACC
synapses, bath application of selective NMDA
receptorNR2B antagonists significantly reduced but not
blocked the induction of LTP by the pairing protocol [16].
Similarly, in the lateral amygdala, NMDA receptor NR2B
antagonist Ro 25–6981 significantly reduced NMDA
receptor-dependent LTP induced by a pairing protocol
[28]. In the hippocampal CA1 region, some studies have
reported that the activity of NR2B-NMDARs is not
required for synaptic potentiation or LTP [29]. However,
a previous study using genetic overexpression of NR2B
subunits indicate the involvement of NMDA NR2B recep-
tor. In the hippocampus of transgenic mice with NMDA
NR2B overexpression, LTP induced by tetanic stimulation
or repetitive stimulation were significantly enhanced as
compared with wild-type littermates [30] (Figure 1).
Considering that NR2B- and NR2A- NMDA receptors
have different biophysical properties and couple to differ-
ent intracellular signaling cascades, it may be possible that
different induction protocols may activate different
NMDA receptor subtypes. It has been reported that differ-
ent LTP-inducing protocols recruit different signaling
pathways. For example, in the amygdala, pairing-protocol
induced LTP depends on L-VGCCs but not NMDA recep-
tors, while tetanus-stimulation induced LTP involves
NMDA receptor but not L-VGCCs [31]. Recently, we have
shown that the involvement of NR2B-NMDA receptors in
hippocampal LTP are dependent on induction protocols
[32,33]. NR2B-NMDA receptors are required for LTP
induced by the spike-timing protocol, but not by the pair-
ing protocol [5]. The same dose of Ro 25–6981 reduced
LTP induced by the spike-timing protocol, but not by the
pairing protocol. Interestingly, neither LTP induced by
two train tetanic stimulation nor late-phase LTP induced
by multiple train stimulation was affected by NR2B antag-
onist Ro 25–6981. Furthermore, calcium imaging studies
showed that the NR2B-NMDA receptor mediated Ca2+
transients were faster under the spike-timing than pairing
protocols, which might explain the different significance
of NR2B-NMDARs in LTP under the two protocols since
fast Ca2+ transients are better for LTP, but slow Ca2+ tran-
sients not [5].
Requirement of NMDA receptor NR2B subunit 
in behavioral learning
Although the NMDA NR2B receptor antagonists have
been available for a few years, there are a few studies that
have investigated the contribution of NMDA NR2B recep-
tors to behavioral learning. For spatial water maze mem-
ory, it has been reported that 60-min pretreatment with
(+/-)-CP-101,606 (60 mg/kg, p.o.), a dose that fully occu-
pied hippocampal NR1/NR2B subunit-containing recep-
tors, as determined by ex vivo NMDA receptor-specific
[3H]ifenprodil binding immediately following water maze
experiments, had no effect on acquisition or the probe
trial. These results suggest that antagonists selective for
NR1/NR2B subunit-containing receptors may not impair
spatial memory in rats in the Morris water maze [34].
Unlike spatial memory, the contribution of NMDA NR2B
receptors to fear memory has been reported. Systemic
injections of NMDA NR2B receptor antagonist ifenprodil
before training led to a dose-dependent impairment in the
acquisition of auditory and contextual fear conditioning,
whereas injections before testing had no effect [35].
Recently, similar administration of NMDA receptor NE2B
subunit antagonist Ro 25–6981 significantly attenuated
fear extinction but not re-extinction recall [36]. In the hip-
pocampal CA1 region, pre-training intra-CA1 infusion of
ifenprodil or Ro 25–6981 impaired the contextual fear
memory induced by five CS-US pairings, with no effect on
the memory induced by one conditioned stimulus (CS)-
unconditioned stimulus (US) pairing [5]. These findings
are in good accord with previous genetic studies that fore-
brain NR2B overexpression enhanced spatial and fear
memory [30]. Furthermore, intra-amygdala infusions of
ifenprodil mirrored systemic injection results and, in
addition, showed that the effects are attributable to a dis-
ruption of fear learning rather than a disruption of mem-Page 3 of 11
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Genetic overexpression of NMDA NR2B receptors in forebrains enhanced central synaptic potentiationFigure 1
Genetic overexpression of NMDA NR2B receptors in forebrains enhanced central synaptic potentiation. a. Syn-
aptic potentiation induced by a single tetanic stimulation (100 Hz, 1 sec) was significantly enhanced in NR2B transgenic mice 
compared with wild-type littermates; b. Enhancement of synaptic potentiation is frequency-dependent, and LTD induced by 
low-frequency stimulation (1 Hz, 15 min) was not affected din NR2B transgenic mice. Modified from Tang et al (1999). Zhuo's 
lab contributed to the plasticity studies in this original article.
Molecular Brain 2009, 2:4 http://www.molecularbrain.com/content/2/1/4ory consolidation. NMDA receptors in lateral amygdala
are thus involved in fear conditioning, and the NR2B sub-
unit appears to make unique contributions to the under-
lying plasticity [35]. In addition to the amygdala, a recent
study indicates that neurons in the ACC may also contrib-
ute to the formation of fear memory. Inhibition of NMDA
NR2B functions in the ACC by local microinjection of
pharmacological NR2B antagonists or NR2B siRNA
manipulation significantly reduced fear memory [16],
suggesting that cortical NMDA receptor NR2B subunit
also contribute to fear memory formation.
NMDA NR2B receptor does not undergo 
potentiation in memory storage
Unlike AMPA receptors during early phase memory, it is
generally believed that NMDA receptors do not undergo
rapid and prolonged changes during memory (or hippoc-
ampal LTP) (Table 2). Systemic administration of NMDA
NR2B antagonists after the training and before the testing
did not affect fear memory [35]. Consistent with this find-
ing, AMPA receptor mediated responses are found to be
enhanced after fear conditioning in the amygdala and
NMDA-mediated transmission in the thalamic-to-lateral
amygdala pathway is not facilitated after fear condition-
ing. Western blots show a reduction in phosphorylated-
NR1, NR2A, and NR2B subunit protein expression in the
Table 1: Summary of the involvement of NMDA receptor NR2B subunit in synaptic LTP
Brain region Pharmacological inhibitors or genetic 
manipulation
Induction protocol Effects on LTP Reference
ACC NR2B antagonist Pairing protocol Reduced Zhao et al., 2005
Spike-timing protocol Blocked
Theta burst stimulation (TBS) blocked
Perirhinal cortex NR2B antagonist High frequency stimulation (HFS) No effect Massey et al., 2004
Visual cortex NR2B antagonist Pairing protocol blocked Yoshimura et al., 2003
Hippocampal CA1 NR2B overexpression HFS or repetitive stimulation Enhanced Tang et al., 1999
HFS No effect Liu et al., 2004
NR2B antagonist Pairing protocol No effect
HFS Reduced Berberich et al., 2007
Pairing protocol Blocked
HFS No effect Zhang et al., 2008
Pairing protocol No effect
Spike-timing protocol blocked
Amygdala NR2B antagonist Pairing protocol Reduced Miwa et al., 2008
Spinal dorsal horn ND ND ND
Table 2: Summary of the involvement of NMDA receptor NR2B subunit in behavioral memory and chronic pain
Brain function Drug or manipulation Brain regions Effects Reference
Spatial memory 
(Morris water maze)
NR2B overexpression Forebrain Enhanced fear memory Tang et al., 1999
NR2B antagonist Systemic injection No effect Guscott et al., 2003
Fear memory NR2B overexpression Forebrain Enhanced fear memory Tang et al., 1999
NR2B antagonist Amygdala Blocked acquisition Rodrigues et al., 2001
No effect on expression of fear
NR2B antagonist Amygdala Inhibit fear conditioning without 
effect on fear expression
Walker and Davis, 2008
Chronic pain NR2B overexpression Forebrain Enhancing chronic pain Wei et al., 2002
NR2B antagonist ACC Inhibiting chronic pain Wu et al., 2005Page 5 of 11
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least three possible physiological significances for the
reduction in NMDA receptor NR2B functions [37]. First,
the down-regulation of the NMDA receptor may protect
against neuronal excitotoxicity of unchecked NMDA
receptor recruitment during the induction and consolida-
tion of fear memories. It is well known that NMDA NR2B
receptor antagonists have neuroprotective effects. Second,
reduced NMDA current and protein may allow persistence
of the "capacity to reactivate" amygdala pathways for the
induction of future fear memories. The overexcitation
caused by the upregulation of NMDA receptors may pre-
vent the formation of new fear memory that is critical for
animals to survive in the natural environment. Finally, a
persistent long-term depression of NMDA transmission
may occur after fear learning [37]. Similar results have
been found in the visual cortex. Experience-dependent
plasticity is reported to cause changes in the NR2A:NR2B
ratio, favoring the expression of NMDA receptor NR2A
subunit [38-41].
Upregulation of NMDA receptor NR2B subunit 
functions in chronic pain
In NMDA receptor NR2B subunit genetically overexpres-
sion mice, we found that chronic pain – but not acute or
physiological pain – was selectively enhanced [30,42] (see
Figure 2), providing the first genetic evidence that fore-
brain NMDA NR2B receptor is critical for chronic pain.
This finding also offers additional reasons to explain why
NMDA NR2B receptor is not undergoing upregulation
during learning (see above). Does genetically overexpres-
sion of NR2B mimic physiological or pathological condi-
tions? In a recent study we found that after persistent
inflammation (the Complete Freund's Adjuvant (CFA)
animal model for chronic inflammation), the expression
of NMDA NR2B receptors in the ACC was increased over
a long-period of time, thereby increasing the NR2B com-
ponent in NMDA receptor mediated EPSCs [17] (see Fig-
ure 3A, B). In the behavioral allodynia test, microinjection
into the ACC or systemic administration of NMDA NR2B
receptor with selective antagonists inhibited behavioral
responses to peripheral inflammation [17]. These results
are consistent with genetic studies that mice with NMDA
receptor NR2B subunit forebrain overexpression selec-
tively enhanced inflammation-related persistent pain
without significant changes in acute pain [43]. The anti-
allodynic effects of NMDA NR2B receptor antagonists
have been also reported in other animal models of
chronic pain. We believe that these findings provide direct
evidence that NMDA NR2B receptors undergo long-term
plastic changes in the brain after injury.
Recent studies in other central synapses suggest that
NMDA NR2B receptor up-regulation is likely to be reliant
on activity-dependent mechanisms. The molecular motor
protein KIF 17 has been shown to be involved in the active
transport of NMDA receptor NR2B subunits [44-46].
NR2B contains a cAMP response element-binding protein
(CREB) binding domain which may couple increases in
intracellular calcium with the increase in NR2B expres-
sion. Since NMDA receptors play an important role in
activity-dependent plasticity in the ACC, we suggest that
NMDA NR2B subunit may be regulated through NMDA-
calcium-CaM-dependent signaling pathways. The activa-
tion of NMDA receptors triggers postsynaptic calcium,
leading to the activation of calcium-stimulated CREB in
the ACC after peripheral or central injury [42] (see Figure
4).
cAMP as a key second messenger
Studies using gene knockout of calcium-calmodulin
dependent adenylyl cycles AC1 and AC8 revealed that
AC1 pays key roles in triggering injury related central plas-
ticity. In AC1 knockout mice, LTP, a likely synaptic model
for chronic pain in the cortex, was completely abolished
[47]. The effects of inhibition of AC1 are selective as both
basal synaptic responses (mostly mediated by AMPA
receptor) and NMDA receptor mediated responses were
not affected [47,18]. Because of the ACC LTP induced by
the paring protocol is mediated by postsynaptic AMPA
receptor (likely through postsynaptic receptor trafficking)
[48], it is suggested that AC1 activity is critical for calcium-
triggered AMPA receptor trafficking. Consistent with in
vitro slice findings, behavioral responses in different ani-
mal models of chronic pain are significantly reduced or
blocked in AC1 knockout mice.
Recent studies using the animal model of neuropathic
pain actually show that postsynaptic AMPA receptor
mediated responses are enhanced in the ACC synapses of
mice receiving nerve injury. The enhancement of AMPA
receptor mediated EPSCs is likely through the phosphor-
ylation of postsynaptic AMPA receptor GluR1 subunit at
PKA site [6]. Such nerve injury triggered enhancement of
postsynaptic responses and GluR1 receptor phosphoryla-
tion are abolished in AC1 knockout mice, suggesting that
AC1 dependent-cAMP pathway is important. In addition
to postsynaptic mediated effects, presynaptic enhance-
ment of glutamate releases in the ACC synapses have been
also found, and AC1 is also required for triggered these
presynaptic changes [6]. It remains to be investigated if
such AC1 contribution is directly on presynaptic termi-
nals, or act through possible retrograde messengers in the
ACC [18].
Studies using AC1 knockout mice also demonstrated that
AC1 activity is critical for NR2B upregulation after the
injury. Changes in NMDA NR2B antagonist sensitive
EPSCs caused by the nerve injury were abolished in mice
lacking AC1 (unpublished data). It is possible that NMDAPage 6 of 11
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Selective enhancement of chronic pain in 'smart' mice with NR2B overexpression in forebrainsFigure 2
Selective enhancement of chronic pain in 'smart' mice with NR2B overexpression in forebrains. a. Overexpres-
sion of NR2B mRNA in pain-related forebrain areas including the ACC and insular cortex (IC). No overexpression of NR2B 
was detected in the spinal cord. b. Enhancement of behavioral nociceptive licking responses to peripheral subcutaneous injec-
tion of formalin in NR2B transgenic mice. c. Summarized three different phases of behavioral nociceptive licking responses in 
wild-type and NR2B transgenic mice. Similar increases in behavioral nociceptive responses were found in the second line of 
NR2B transgenic mice. Modified from Wei et al. (2001).
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Peripheral inflammation triggers long-term increases in NMDA NR2B receptor mediated currents in cingulate pyramidal cellsFigur  3
Peripheral inflammation triggers long-term increases in NMDA NR2B receptor mediated currents in cingu-
late pyramidal cells. NR2B sensitive component of NMDA receptor mediated EPSCs were enhanced in mice with CFA 
injection. a. Traces of EPSCs show the currents at different time points during application of drugs. Ro 25–6981 produced its 
maximal effect at 3 min after bath application, and a higher dose of Ro 25–6981 (3 μM) had no additional effects. The remaining 
currents can be totally blocked by AP-5 (50 μM). b. A selective NR2B antagonist, Ro 25–6981, partially inhibited NMDA recep-
tor-mediated EPSCs. The time course of changes in EPSC amplitude before and during the application of Ro 25–6981 (0.3 and 
3 μM) and AP-5 (50 μM) in ACC neurons from both saline (control, open symbols) and CFA-injected (filled sumbols) mice is 
shown. Modified from Wu et al. (2005).
Molecular Brain 2009, 2:4 http://www.molecularbrain.com/content/2/1/4NR2B receptor-AC1-cAMP-CREB-NR2B form a positive
cellular feedback to reinforce the NMDA receptor func-
tions in the ACC neurons. Together with NMDA receptor
mediated AMPA receptor potentiation, these synaptic
changes greatly enhance excitatory synaptic transmission
in the ACC after the injury, and thus contribute to cortical
pain (see Figure 4).
Clinical considerations for developing NR2B 
agonists as memory enhancers or antagonists as 
pain killers
Based on the discovery of NMDA NR2B receptor functions
in LTP and behavioral memory, there are several propos-
als of developing NMDA NR2B function enhancer to
increase memory functions in so-called low IQ adults or
to rescue the memory loss in the patients. This hypothesis
Central signaling pathways contribute to chronic painFigu e 4
Central signaling pathways contribute to chronic pain. In the ACC, glutamate is the major fast excitatory transmitter 
between input fibers and pyramidal cells. Peripheral injury such as tissue inflammation or nerve injury trigger a burst of abnor-
mal activity in the ACC circuits; and subsequently activate postsynaptic NMDA receptors on cingulate pyramidal cells located 
in layer II-III. Activation of NMDA receptor triggers calcium influx. In adult ACC pyramidal cells, most of NMDA receptors are 
the combination of NR1-NR2A, NR1-NR2B with possible minor component of currents made of NR1-NR2A-NR2B. Postsyn-
aptic increases in Ca2+ leads to activation of Ca2+-calmodulin (CaM) dependent pathways. Among them, Ca2+ and CaM stimu-
lated AC1 is activated, and this activation leads to the generation of the key second messenger cAMP. Subsequently, cAMP 
activates PKA. PKA then translocates to the nucleus and phosphorylates CREB. NR2B contains a CREB binding domain which 
may couple increases in intracellular calcium with the increase in NR2B expression. Subsequently, postsynaptic synthesis of 
NMDA NR2B is increased, and together with endogenous motor protein KIF17, these new NR2B subunits are added to post-
synaptic NMDA receptors. Such positive feedback control may further enhance neuronal excitability within the ACC, and con-
tribute to chronic pain.Page 9 of 11
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ment enrichment in that both NMDA NR2B functions
and behavioral learning are significantly enhanced. How-
ever, considering the negative finding of NMDA NR2B
receptors in the expression of memory, it is unlikely that
enhancing NMDA NR2B functions will be beneficial for
maintaining newly formed memory (see above). Further-
more, enhancing NMDA NR2B functions may enhance
chronic pain in case of any tissue or nerve injury [18]. In
addition to chronic pain, the potential roles of NMDA
NR2B receptors in cell death, seizure have been reported.
Enhancing NR2B receptors may also enhance these poten-
tial risks.
To use the NMDA receptor NR2B antagonists to control
brain disease and chronic pain have been reported by
many groups. For example, in the case of chronic pain, it
has been reported that NR2B antagonists produced pow-
erful analgesic effects in animal models of chronic pain
(see above). The action off site for NR2B antagonist is
mainly due to cortical NR2B receptors, although it may
also exert some of its effects in the spinal cord level. Alter-
natively, in the case that side effects in humans are found
with NR2B antagonists, one may target on downstream
proteins such as AC1. In summary, we are just beginning
to understand how central synapses may undergo plastic
changes during learning or after peripheral tissue injury,
understanding basic mechanisms for such long-term plas-
ticity may help us to design better medicines for treating
memory loss and chronic pain.
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